MICHAEL SCHEURER to Human papillomavirus 16
This is a "connection" page, showing publications MICHAEL SCHEURER has written about Human papillomavirus 16.
Connection Strength
1.133
-
Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. Gynecol Oncol. 2018 02; 148(2):357-362.
Score: 0.532
-
Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia. Cancer Prev Res (Phila). 2023 08 01; 16(8):461-469.
Score: 0.196
-
A paper-based immunoassay to determine HPV vaccination status at the point-of-care. Vaccine. 2016 11 04; 34(46):5656-5663.
Score: 0.122
-
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Head Neck. 2016 09; 38(9):1330-7.
Score: 0.118
-
Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S163-9.
Score: 0.065
-
A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care. Sci Rep. 2023 11 21; 13(1):20397.
Score: 0.050
-
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings. Sci Transl Med. 2023 06 21; 15(701):eabn4768.
Score: 0.049